NCT07588243进行中（未招募）不适用
A Pivotal Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth
CynosureLutronic4 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2026年2月19日最近更新:
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 44
- 试验地点
- 4
研究概览
简要总结
The goal of this clinical study is to evaluate the efficacy and safety of the Ultra device for the treatment of hair regrowth by assessing the improvement of hair density and hair shaft diameter.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 22 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •22 - 70 years old
- •Is willing to undergo study device use.
- •Fitzpatrick skin type I-VI
- •Clinical diagnosis of androgenetic alopecia (Norwood-Hamilton II-V or Ludwig I-II)
- •Willing to avoid significant changes to hair (such as drastic haircuts and dying hair) during their involvement in the study.
- •Willing to maintain current diet and exercise routine throughout study duration.
- •Understands and accepts the study condition to not receive any other procedures to the treatment area or to undergo any procedures, take any medications, supplements, or partake in any other treatments indicated for hair growth throughout the length of the study.
- •Understands and accepts the study condition of and agrees that he or she is able to be present for all study visits.
- •Willing to comply with all requirements of the study and is able to provide written informed consent.
排除标准
- •Is female and pregnant, has been pregnant within the last 3 months, is currently breast feeding, or planning a pregnancy during the study period.
- •Has a diagnosis of other forms of alopecia (e.g., scarring alopecia, alopecia areata)
- •Has recent use (within 6 months) of a systemic hair growth medications (e.g., oral finasteride).
- •Inconsistent use of vitamins that can affect hair growth - must have stabilized use for at least 6 months prior to first treatment.
- •Had previous treatment (such as laser or topical) to scalp within 6 months.
- •Has a malignant disease, cancer, or uncontrolled medical condition.
- •Has an impaired immune system due to immunosuppressive diseases, such as AIDS and HIV, or use of immunosuppressive medications
研究组 & 干预措施
Ultra Treatment
Experimental
干预措施: Low Level Laser Therapy (Device)
研究者
研究点 (4)
Loading locations...
相似试验
尚未招募
4 期
supraclavicular subclavain vein v/s IJV cannulation which is safe and better in adult pateint requiring GA.CTRI/2025/11/097652MGM Medical college and Hospital Aurangabad60
尚未招募
Unknown
A study to see if the Density Device helps improve loose skin in people losing weight with GLP-1/GIP medicines.CTRI/2025/10/096688Jeisys Medical Inc.18
尚未招募
不适用
Monitoring Disease Activity in Patients With Takayasu Arteritis With the OMERACT Takayasu Ultrasound Score (OTUS)Takayasu Arteritis (TAK)NCT07571577IRCCS San Raffaele100
尚未招募
4 期
A Study Comparing Two Methods of Numbing a Nerve During Sinus SurgeryCTRI/2026/02/103825AIIMS Nagpur60
进行中（未招募）
不适用
Evaluating Universal Adhesives in Cervical LesionsNCT07459374Hacettepe University30